Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HMGCR | P04035 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ACLY | P53396 | 3/20 | 0.39 |
| ▸ | MVD | P53602 | 1/20 | 0.36 |
| ▸ | CPT2 | P23786 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL27725522 | 0.94 | ALDH1A1 (0.38) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL3515860 | 0.84 | HMGCR (0.40) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL544773 | 0.79 | ALDH1A1 (0.50) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL11507779 | 0.73 | MVD (0.47) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL631254 | 0.73 | — | — | |
| SCHEMBL5884075 | 0.73 | TSHR (0.35) | ALDH1A1TSHR | |
| SCHEMBL27742868 | 0.73 | — | — | |
| SCHEMBL9770202 | 0.71 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL12386935 | 0.71 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| SCHEMBL4807365 | 0.71 | ALDH1A1 (0.43) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150380769-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC CORPORATION (JP) | 2015-12-31 | — | — | US | claimed |
| US-20240213548-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE PRECURSOR, ELECTROCHEMICAL DEVICE, AND METHOD OF PRODUCING ELECTROCHEMICAL DEVICE | MITSUI CHEMICALS, INC. (JP) | 2024-06-27 | — | — | US | disclosed |
| EP-4310973-A1 | NON-AQUEOUS ELECTROLYTE, ELECTROCHEMICAL DEVICE PRECURSOR, ELECTROCHEMICAL DEVICE, AND METHOD FOR PRODUCING ELECTROCHEMICAL DEVICE | Mitsui Chemicals, Inc. (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20230044513-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20220199967-A1 | POSITIVE ELECTRODE ACTIVE MATERIAL FOR NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2022-06-23 | — | — | US | disclosed |
| US-10374259-B2 | Hydrofluoroether compound, nonaqueous electrolyte solution and lithium ion secondary battery | NEC CORPORATION (JP) | 2019-08-06 | — | — | US | disclosed |
| CN-109134216-A | A kind of preparation method of trifluoromethyl substituted carboxylic acid compound | 浙江九洲药业股份有限公司 | 2019-01-04 | — | — | CN | disclosed |
| US-20180115020-A1 | HYDROFLUOROETHER COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM ION SECONDARY BATTERY | NEC CORPORATION (JP) | 2018-04-26 | — | — | US | disclosed |
| US-20150380769-A1 | NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | PANASONIC CORPORATION (JP) | 2015-12-31 | — | — | US | disclosed |
| CN-103172515-A | Preparation method of 3,3,3-trifluoromethyl propionate | XIAN MODERN CHEMISTRY RES INST | 2013-06-26 | — | — | CN | disclosed |
| CN-103172515-A | Preparation method of 3,3,3-trifluoromethyl propionate | XIAN MODERN CHEMISTRY RES INST | 2013-06-26 | — | — | CN | disclosed |
| US-20090181994-A1 | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | MERCK & CO., INC. (US) | 2009-07-16 | — | — | US | disclosed |
| US-7504402-B2 | Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1 | MERCK & CO., INC. (US) | 2009-03-17 | — | — | US | disclosed |
| EP-1581515-B1 | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | MERCK & CO INC (US) | 2007-10-10 | — | — | EP | disclosed |
| EP-1581515-A1 | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | Merck & Co., Inc. (US) | 2005-10-05 | — | — | EP | disclosed |
| US-20050154038-A1 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | MERCK SHARP & DOHME LLC | 2005-07-14 | — | — | US | disclosed |
| US-6849636-B2 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | MERCK & CO., INC. (US) | 2005-02-01 | — | — | US | disclosed |
| WO-2004058741-A1 | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | MERCK & CO., INC. (US) | 2004-07-15 | — | — | WO | disclosed |
| US-20040133011-A1 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | MERCK SHARP & DOHME LLC | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374259-B2 | Hydrofluoroether compound, nonaqueous electrolyte solution and lithium ion secondary battery | NHERF1, SLC9A1, SLC9A2 | ALDH1A1 1281/4885HMGCR 4362/4885CHRM1 1718/4885 |
| US-20050154038-A1 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | HSD11B1, HSD17B1, HSD3B1 | ALDH1A1 145/4885HMGCR 67/4885CHRM1 4027/4885 |
| US-20040133011-A1 | Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 | HSD11B1, HSD17B1, HSD3B1 | ALDH1A1 146/4885HMGCR 69/4885CHRM1 3855/4885 |
| US-20090181994-A1 | TRIAZOLE DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 | HSD11B1, HSD17B1, HSD3B1 | ALDH1A1 145/4885HMGCR 67/4885CHRM1 4027/4885 |
| US-20180115020-A1 | HYDROFLUOROETHER COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM ION SECONDARY BATTERY | NHERF1, SLC9A1, SLC9A2 | ALDH1A1 1281/4885HMGCR 4362/4885CHRM1 1718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.